Q&A With Dr. Hugh Harvey

The Medical Imaging Convention is the UK’s dedicated trade show for the medical imaging industry and will emanate from the National Exhibition Centre, Birmingham on the 26th and 27th of March 2019. With an educational stream contributed by a line up of industry experts, we had the chance to speak with Dr. Hugh Harvey, Clinical Director at Kheiron Medical, to find out more about his research and the impact his work will have on the wider industry. Dr. Hugh Harvey is currently working to implement deep learning software into the NHS breast screening programme, making him a foremost expert in the application of AI and machine learning.

Tell me a little bit more about your background

I am a board certified radiologist and clinical academic, and trained in the NHS and Europe’s leading cancer research institute, the ICR, where I was twice awarded Science Writer of the Year! Previously a consultant radiologist at Guys & St Thomas’, I am now a Royal College of Radiologists informatics committee and AI advisory board member, as well as the clinical director at Kheiron Medical, an AI company focussed on deep learning in breast cancer, and also co-chair of the government Topol Review into AI in healthcare.

What are you currently working on? What are the challenges and benefits of it?

I am working on integrating Kheiron's deep learning software, Mia, into the NHS breast screening programme as an independent reader of mammograms. This has the potential to drastically reduce the workload on the screening workforce, and aid in faster double reading turn-around time. The challenges are many!

What impact does this have on the field in a larger sense?

There is the potential for deep learning to pre-screen, triage, quality assure and perform second reading in all forms of screening that involves medical imaging, from breast screening to lung cancer, and maybe even prostate cancer in the future.

What does the future for the field of AI and machine learning in medical imaging look like?
AI will be integral to all forms of medical imaging, not only in the interpretive clinical work, but also in the back-end processes. These will include scheduling, image acquisition, integration with health records, and communication of findings with both physicians and patients.

What are your expectations for speaking at the Medical Imaging Convention?
To engage a wider audience on the benefits of deep learning technology in screening, and also to listen and learn from the other excellent speakers.

Dr. Hugh Harvey will be leading his keynote seminar in the AI & Deep Learning Theatre at the Medical Imaging Convention on the 26th and 27th March. If you want to find out more about Dr. Hugh Harvey, you can look at his full speaker profile and also see the full speaker line up you will see at the show.  


Tickets for the event are freely available from the link at the top of the page. Tickets to the Medical Imaging Convention will grant you access to the co-located European Neuro Convention and the European Oncology Convention as well.